NUCALA sol inj 100 mg/ml seringue préremplie
7680673510018
CH-67351
R03DX09
03.04.5.
Reimbursement limitations:
NUCALA.01
Asthme éosinophilique sévère
Seuls les médecins spécialistes en pneumologie, en allergologie et en immunologie sont …
1 / 3
google
Details
- Product number
- 6735101
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- mepolizumabum 100 mg, saccharum, dinatrii phosphas heptahydricus, acidum citricum monohydricum, polysorbatum 80 dinatrii edetas, aqua ad iniectabile q.s. ad solutionem pro 1.0 ml.
Articles (1)
Nucala 100 mg/mL, Injektionslösung in der Fertigspritze
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 1078.55
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/04/2020
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 67351
- Drug name
- Nucala, Injektionslösung in der Fertigspritze
- Galenic form
- INLFS
- ATC Code
- R03DX09
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 13/02/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 03.04.5.
- Domain
- Human medicine
Packaging details
- Description (FR)
- NUCALA sol inj 100 mg/ml seringue préremplie
- Description (DE)
- NUCALA Inj Lös 100 mg/ml Fertigspritze
- Market launch
- 13/02/2020
- Narcotic (BTM)
- No